Indo Borax Takes Control of Kronox Lab Sciences

Indo Borax & Chemicals Limited has acquired 2,38,44,000 equity shares of Kronox Lab Sciences, representing a 64.26% stake.
An open offer to acquire an additional 95,70,000 shares (25.79% stake) has been initiated by the acquirer and its concert parties.

Reader Takeaway: Control shifts to Indo Borax as original promoters exit; open offer provides liquidity exit for public shareholders.

What just happened

Kronox Lab Sciences has completed a formal change of control. Following a Share Purchase Agreement dated August 20, 2026, Indo Borax & Chemicals Limited has taken over as the new promoter. The company has officially recognized this transition, and the former promoter group is now moving to reclassify as public shareholders.

Why this matters

The acquisition marks a fundamental shift in leadership for Kronox Lab. With the former promoters—Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani, and Jogindersingh Gianchand Jaswal—surrendering control and board representation, the company is undergoing a complete management and ownership overhaul.

Promoter Re-classification

The outgoing promoters have reduced their collective holding to 9.95%. They have confirmed compliance with SEBI Listing Regulations (Regulation 31A), verifying that they no longer hold special rights, board seats, or management influence. This process is pending final regulatory clearance.

The Open Offer

Indo Borax and Zenrock Chemicals are currently executing a mandatory open offer for 25.79% of the company's equity capital. This offer, aligned with SEBI's takeover norms, provides an opportunity for existing public shareholders to exit their positions to the new controlling entity.

What to track next

Investors should monitor the outcome of the open offer and any potential regulatory hurdles regarding the final approval of the promoter reclassification. The integration process and any strategic shifts implemented by the new board will be critical for long-term stock performance.